Class 005: Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Education services, namely, providing instruction by means of online tutorial sessions in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Downloadable printable educational materials, downloadable newsletters, and downloadable webinars in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Printed newsletters, pamphlets and brochures in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Providing web conferencing services and telephone conferencing services in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Patient consumer support, namely, providing consumer product information in the field of pharmaceuticals via a website and telecommunications networks; patient support services, namely, business administration related to treatment access via a website and telecommunications networks; Providing medical information relating to disease treatment and compliance to disease treatment; Pharmaceutical advice; Medical counseling relating to disease treatment and compliance to disease treatment; providing patient support services, namely, providing medical information and pharmaceutical advice featuring treatment guidance, prescribing information, assistance with prescription usage, and medical safety information
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Pharmaceutical preparations for treatment of diabetes complications; Pharmaceutical preparations for treatment of heart diseases or disorders, eye diseases or disorders, nervous system diseases or disorders, kidney diseases or disorders, cardiomyopathy, neuropathy, retinopathy, and nephropathy; Pharmaceutical preparations for inhibiting aldose reductase
Education services, namely, providing instruction by means of online tutorial sessions in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Downloadable printable educational materials, downloadable newsletters, and downloadable webinars in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Providing web conferencing services and telephone conferencing services in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Printed newsletters, pamphlets and brochures in the fields of disease education, disease treatment, compliance to disease treatment regimen, and treatment access; Patient consumer support, namely, providing consumer product information in the field of pharmaceuticals via a website and telecommunications networks; patient support services, namely, business administration related to treatment access via a website and telecommunications networks; Providing medical information relating to disease treatment and compliance to disease treatment; Pharmaceutical advice; Medical counseling relating to disease treatment and compliance to disease treatment; providing patient support services, namely, providing medical information and pharmaceutical advice featuring treatment guidance, prescribing information, assistance with prescription usage, and medical safety information
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Class 035: Promoting public awareness of metabolic diseases, namely, galactosemia; Promoting the exchange of information and resources among individuals impacted by galactosemia to educate the public and impacted communities about the disease; Promoting collaboration among patients, caregivers, parents, metabolic dietitians, and clinicians to educate the public and communities impacted by galactosemia about the disease; Class 044: Providing medical information and news about galactosemia via the internet
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
